The Pharmaelle project


Pharmaelle's research and development strategy is patient-focused. The constant work of our researchers is meant to develop new products and to provide innovative responses to clinical needs yet to be met.
The end goal for us is always the same: ensuring patients with significant benefits.
We are concentrating on the therapeutic areas where we valuate the greatest unmet clinical needs, such as genetically transmitted diseases which to date still represents one of the most complex challenges for science.
It is specifically for the field of genetic transmission diseases, such as ALD (Adrenoleukodystrophy) and FC (Cystic Fibrosis) that we have developed a portfolio of exclusive and innovative products.

As of now, we are running several dozen research and development projects in the area of genetic diseases and in that of nutritional management of patients recovering from bariatric surgery.

Investments on research and development


The 2016 turnover compared to the previous year

New items in the Barilife®  product line


Our commitment towards research and development as well as our desire to boost the levels of training and of information in the medical field make us particularly active at medical and industry conferences.
Sharing as the main way to advance medical progress. Sharing as a basic tool to generate the enthusiasm necessary to never stop. Sharing as a way of life, so as to never forget the end goal of our work: the health of patients.


Pharmaelle promotes several socially responsible activities that bear witness to our commitment towards the community.
One such example is the ALD-AMN Care Project meant as a support project for the Italian Association for Adrenoleukodystrophy.
We provide support to this Association; whose goal is to speed up the process in as far as developing knowledge and new therapies in the fight against Adrenoleukodystrophy. We are working side by side with it in the constant effort to create improved medical and social care conditions for all people as well as in raising awareness about the disease.